Clinical Trials
26
Active:26
Completed:0
Trial Phases
1 Phases
Phase 1:19
Drug Approvals
247
CIMA_AEMPS:145
NMPA:55
EMA:46
+1 more agencies
Drug Approvals
Ceftolozane Sulfate and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢洛生他唑巴坦钠
- Approval Number
- 国药准字HJ20250016
- Approval Date
- Feb 8, 2025
NMPA
Imipenem, Cilastatin Sodium and Relebactam for Injection
- Product Name
- 注射用亚胺西瑞
- Approval Number
- 国药准字HJ20240140
- Approval Date
- Dec 1, 2024
NMPA
Imipenem, Cilastatin Sodium and Relebactam for Injection
- Product Name
- 注射用亚胺西瑞
- Approval Number
- 国药准字HJ20240141
- Approval Date
- Dec 1, 2024
NMPA
Ertapenem Sodium for Injection
- Product Name
- 怡万之
- Approval Number
- 国药准字HJ20150481
- Approval Date
- Nov 29, 2024
NMPA
Ertapenem Sodium for Injection
- Product Name
- 怡万之
- Approval Number
- 国药准字HJ20150480
- Approval Date
- Nov 29, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 1
19 (100.0%)No trials found
News
No news found